Search Results - "Bürgisser, P."

Performance evaluation of a new fourth-generation HIV combination antigen–antibody assay by Mühlbacher, A., Schennach, H., van Helden, J., Hebell, T., Pantaleo, G., Bürgisser, P., Cellerai, C., Permpikul, P., Rodriguez, M. I., Eiras, A., Alborino, F., Cunningham, P., Axelsson, M., Andersson, S., Wetlitzky, O., Kaiser, C., Möller, P., de Sousa, G.

“…Education and diagnostic tests capable of early detection represent our most effective means of preventing transmission of human immunodeficiency virus (HIV)…”
Get full text

Cook's versus Valiant's hypothesis by Bürgisser, Peter

“…Valiant developed a nonuniform algebraic analogue of the theory of NP-completeness for computations with polynomials over a field k in (Valiant, Proceedings of…”
Get full text

Prolonged seroconversion in an elite controller of HIV-1 infection by Clerc, O, Cavassini, M, Böni, J, Schüpbach, J, Bürgisser, P

“…Abstract HIV-1 diagnosis is usually based on the detection of specific antibodies, appearing in a time-determined pattern following the infection. We describe…”
Get full text

Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants by Mühlbacher, A., Weber, B., Bürgisser, P., Eiras, A., Cabrera, J., Louisirirotchanakul, S., Tiller, F.-W., Kim, H.-S., Helden, J. v., Bossi, V., Echevarria, J.-M.

“…In a multicenter study a new, fully automated Roche Diagnostics Elecsys ® HBsAg II screening assay with improved sensitivity to HBsAg mutant detection was…”
Get full text

Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS) by Scherrer, AU, Hasse, B, Von Wyl, V, Yerly, S, Böni, J, Bürgisser, P, Klimkait, T, Bucher, HC, Ledergerber, B, Günthard, HF

“…Objectives Etravirine (ETV) is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with reduced cross‐resistance to first‐generation NNRTIs, which…”
Get full text

Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV‐1 infection correlates with markers of disease severity and changes towards normalization under treatment by BÜRGISSER, P, HAMMANN, C, KAUFMANN, D, BATTEGAY, M, RUTSCHMANN, O T

“…The relationship between blood CD8+ T lymphocyte subsets, as defined by CD28 and CD38 expression, and plasma viraemia and CD4+ T cells in HIV‐1 infection was…”
Get full text

Management of hepatitis C virus (HCV) infection in drug substitution programs by Witteck, Andrea, Schmid, Patrick, Hensel-Koch, Katharina, Thurnheer, Maria C, Bruggmann, Philip, Vernazza, Pietro

“…In Switzerland, intravenous drug use (IDU) accounts for 80% of newly acquired hepatitis C virus (HCV) infections. Early HCV treatment has the potential to…”
Get full text

Performance of Five Different Assays for the Quantification of Viral Load in Persons Infected With Various Subtypes of HIV-1 by Bürgisser, Philippe, Vernazza, Pietro, Flepp, Markus, Böni, Jürg, Tomasik, Zuzana, Hummel, Urs, Pantaleo, Giuseppe, Schüpbach, Jörg

“…Five methods for the assessment of plasma viral load (VL) were evaluated in 103 seropositive patients infected with various subtypes of HIV-1. The methods…”
Get full text

Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient by GREUB, Gilbert, MAZIERO, Annick, BÜRGISSER, Philippe, TELENTI, Amalio, FRANCIOLI, Patrick

“…After occupational exposures, immediate HIV testing of source patients may avoid the unnecessary use of post-exposure prophylaxis (PEP). Two time periods were…”
Get full text

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study by Greub, G, Ledergerber, B, Battegay, M, Grob, P, Perrin, L, Furrer, H, Burgisser, P, Erb, P, Boggian, K, Piffaretti, J-C, Hirschel, B, Janin, P, Francioli, P, Flepp, M, Telenti, A

“…Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-infected individuals, but its contribution to the morbidity and mortality of coinfected…”
Get full text

Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi by Weber, B, Orazi, B, Raineri, A, Thorstensson, R, Bürgisser, P, Mühlbacher, A, Areal, C, Eiras, A, Villaescusa, R, Camacho, R, Diogo, I, Roth, H J, Zahn, I, Bartel, J, Bossi, V, Piro, F, Atamasirikul, K, Permpikul, P, Webber, L, Singh, S

“…Fourth-generation screening assays which permit a simultaneous detection of human immunodeficiency virus (HIV) antigen and antibody reduce the diagnostic…”
Get more information

Beta-2-microglobulin--a rapid and automated determination for a broad range of clinical applications by Henne, V, Frei, P, Bürgisser, P

“…The clinical evaluation of the Cobas Core beta 2-Microglobulin EIA was performed on the random access analyzer Cobas Core. The coefficients of variations for…”
Get more information

PB0816 Phenotypic Characterization of von Willebrand Disease Type 3 Patient-Derived ECFCs with a Homozygous p.M771V Mutation by Bär, I., Bürgisser, P., van Kwawegen, C., Voorberg, J., Eikenboom, J., Leebeek, F., Bierings, R.

Get full text

Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation by Mayerat, C, Bürgisser, P, Lavanchy, D, Mantegani, A, Frei, P C

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers by KÄMMERER, R, ITEN, A, FREI, P. C, BÜRGISSER, P

“…CD28 is a transmembrane glycoprotein that provides T cells with an essential co-stimulatory signal during antigen presentation. Using flow cytometry, we…”
Get full text

Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy by Clifford, Gary M., Polesel, Jerry, Rickenbach, Martin, Dal Maso, Luigino, Keiser, Olivia, Kofler, Andreas, Rapiti, Elisabetta, Levi, Fabio, Jundt, Gernot, Fisch, Thomas, Bordoni, Andrea, De Weck, Daniel, Franceschi, Silvia

“…Background: Persons infected with human immunodeficiency virus (HIV) have an increased risk for several cancers, but the influences of behavioral risk factors,…”
Get full text

Ageing with HIV: medication use and risk for potential drug-drug interactions by Marzolini, Catia, Back, David, Weber, Rainer, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Khoo, Saye, Battegay, Manuel, Elzi, Luigia

“…Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and…”
Get full text

Monitoring Responses to Antiretroviral Treatment in Human Immunodeficiency Virus Type 1 (HIV-l)—Infected Patients by Serial Lymph Node Aspiration by Bürgisser, Philippe, Spertini, François, Weyrich-Suter, Catherine, Pagani, Jean-Luc, Meylan, Pascal R. A.

“…Fine-needle aspiration was used to collect lymph node cells (LNC) from 9 antiretroviral-naive patients entering a double-blind single- or combined-drug study…”
Get full text

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study by Lubomirov, Rubin, Colombo, Sara, di Iulio, Julia, Ledergerber, Bruno, Martinez, Raquel, Cavassini, Matthias, Hirschel, Bernard, Bernasconi, Enos, Elzi, Luigia, Vernazza, Pietro, Furrer, Hansjakob, Günthard, Huldrych F., Telenti, Amalio

“…Background. Poor tolerance and adverse drug reactions are main reasons for discontinuation of antiretroviral therapy (ART). Identifying predictors of ART…”
Get full text

Frequency and Determinants of Unprotected Sex among HIV-Infected Persons: The Swiss HIV Cohort Study by Hasse, Barbara, Ledergerber, Bruno, Hirschel, Bernard, Vernazza, Pietro, Glass, Tracy R., Jeannin, Andre, Evison, John-Marc, Elzi, Luigia, Cavassini, Matthias, Bernasconi, Enos, Nicca, Dunja, Weber, Rainer

“…Background. Access to antiretroviral therapy may have changed condom use behavior. In January 2008, recommendations on condom use for human immunodeficiency…”
Get full text